Experience in Urology
| Indication | Phase | Sample Size | Study Design |
|---|---|---|---|
| Chronic Kidney Disease | 2 | 40 | Multi-center, randomized, double-blind, placebo-controlled, dose escalation study |
| Chronic Kidney Disease | 4 | 300 | Registry |
| Hypoactive Sexual Desire Disorder | 3 | 600 | Randomized discontinuation study containing an open-label, flexible dose period followed by a double-blind, randomized, placebo-controlled period |
| End-Stage Renal Disease | 4 | 10 | Open-label, non-randomized, non-comparative study |